miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells (Q47410403)

15 January 2018

title

miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells (English)

1 reference

15 January 2018

tongue squamous cell carcinoma

main subject

1 reference

Duo Li

1

1 reference

15 January 2018

Ke Liu

2

1 reference

15 January 2018

Zhiyong Li

3

1 reference

15 January 2018

Jian Wang

4

1 reference

15 January 2018

Xiaofeng Wang

5

1 reference

15 January 2018

publication date

13 November 2017

1 reference

15 January 2018

Cell Adhesion and Migration

published in

1 reference

15 January 2018

page(s)

1-11

1 reference

15 January 2018

describes a project that uses

Cytoscape

1 reference

9 June 2022

https://europepmc.org/search?query=(METHODS:'Cytoscape')

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Betaglycan: a multifunctional accessory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Role of TGF-β receptor III localization in polarity and breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Roles for the type III TGF-beta receptor in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Strategies to use microRNAs as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Micronome revealed miR-19a/b as key regulator of SOCS3 during cancer related inflammation of oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Andrographolide inhibits oral squamous cell carcinogenesis through NF-κB inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

The type III TGF-beta receptor suppresses breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Overexpression of transforming growth factor type III receptor restores TGF-β1 sensitivity in human tongue squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

TGFBR3 loss and consequences in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Simvastatin alleviates cardiac fibrosis induced by infarction via up-regulation of TGF-β receptor III expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19336918.2017.1365992

Gene and miRNA expression changes in squamous cell carcinoma of larynx and hypopharynx

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6149514

MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.

2 November 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6149514

Oral carcinogenesis and oral cancer chemoprevention: a review

2 November 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6149514

Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer

2 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29130787

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/19336918.2017.1365992

1 reference

15 January 2018

PMC publication ID

6149514

0 references

1 reference

15 January 2018